Article - $MRNJ - Emerging Growth: Metatron, Inc. Direct

New Post Public Reply Private Reply Replies (0) Message Board
Torch72
Article - $MRNJ - Emerging Growth: Metatron, Inc.

Direct Link:
http://emerginggrowth.com/metatron-inc-otc-pi...rtainment/

Metatron, Inc. (OTC Pink: MRNJ) Growth from Cannabis, Apps & Entertainment
September 21, 2016


Mobile computing has changed the way consumers shop, socialize, play, and more. With thousands of mobile apps available for consumers to download, there really is almost an app for anything that consumers could desire. According to Statista, the number of users in the United States with a smartphone is expected to climb from 207.2 million people to 236.8 million people by 2019. This compares to only 62.6 million Americans that had a smartphone back in 2010.



The mobile revolution in the United States has seen substantial growth over the past many years. However, the latest trend in the mobile app universe is going back to the free app model with a focus on in-app purchases (“freemium” apps). Paid apps were once popular, but have lost their appeal with consumers in recent years. This has forced app developers to transform and convert their mobile applications from paid to free.

One company that stands to benefit from the projected growth in mobile computing and “freemium” apps is Metatron Inc. (OTC Pink: MRNJ).



Overview: Metatron Inc. (OTC Pink: MRNJ)

Metatron Inc (OTC Pink: MRNJ) is a multi-sector business that focuses on acquiring and assimilating fast growing companies with niche business models. Currently, Metatron Inc (OTC Pink: MRNJ) operates the following businesses:

* i-Mobilize: mobile app business
* MyShowNetwork: web services, subscription-based video service
8Cannaboids: CBD/Hemp business
* Appflix: Netflix, Inc. (NASDAQ: NFLX)-style video streaming service with niche, original content
* Crowd-funding entertainment platform: partnered with Circa Pictures to develop a crowd-funding website for entertainment projects

Through Metatron Inc. (OTC Pink: MRNJ)’s i-Mobilize business, the company has created a library of over 2,000 mobile applications, and over 700 apps are currently available for iOS on Apple Inc. (NASDAQ: AAPL) app store and Google’s Android app store. In addition, many of Metatron Inc. (OTC Pink: MRNJ)’s apps have been featured on iTunes’s top 200 U.S. Lifestyle & Wellness list. Being that the company was a major pioneer early on in the mobile app revolution, Metatron Inc. (OTC Pink: MRNJ) was the first company to have a hemp/marijuana themed app on the Apple Inc. (NASDAQ: AAPL) app store. In addition, the company was the first to have a Beatles app on the Apple Inc. (NASDAQ: AAPL) app store. Furthermore, the company has created mobile apps for popular self-help author, Eckhart Tolle, who has sold over 20 million books and was the #1 best-selling author in Oprah’s book club.



Through the years, Metatron Inc. (OTC Pink: MRNJ) has seen over $3.5 million in app sales ($2.3 million net sales from apps) and millions of downloads. Right now, Metatron Inc. (OTC Pink: MRNJ) is in the process of upgrading all 2,000 of the company’s app modules from paid to free, with in-app purchases. This is expected to significantly revamp the i-Mobilize business just in time for the Holiday Season, which historically sees a big jump in mobile app downloads.

MyShowNetwork is a unique business model that helps successful YouTube and web personalities to monetize their web show through a subscription-based model. This allows popular web personalities to capitalize on their vast viewership and increase earnings from the web show. MarkSargent.com is a great example of MyShowNetwork in action. The company helped Mark Sargent take his YouTube show and create a subscription-based website, which will allow Mark to further brand his web show and profit from the vast viewership. There certainly is no shortage of YouTube personalities out there that would no-doubt enjoy a uniquely branded subscription website.

Cannaboids is Metatron Inc. (OTC Pink: MRNJ)’s CBD and hemp business. CBDs are the non-psychoactive ingredient in the marijuana plant and CBDs are actually legal in all 50 U.S. states. The U.S. government classifies CBDs and hemp oil as dietary supplements because they are derived from industrial hemp and do give user the “high” that is associated with THC. Metatron Inc. (OTC Pink: MRNJ) has developed their own line of CBD-infused drinks, which are currently being produced and scheduled to begin distribution later in 2016. Metatron Inc. (OTC Pink: MRNJ) has also signed Pacific Equity Partners, which has been responsible for some big marijuana deals.



Appflix is Metatron Inc. (OTC Pink: MRNJ)’s video streaming service that is currently in development. The Netflix, Inc. (NASDAQ: NFLX)-style streaming service will feature unique, original video content.

Lastly, Metatron Inc. (OTC Pink: MRNJ) has signed a joint venture deal with Circa Pictures, which will focus on the development of an entertainment crowd-funding platform. Content creators looking for funding for their projects will be able to upload a small demo of their project, as sort of an advertisement to get crowd-funders to fund the project.

Metatron Inc (OTC Pink: MRNJ) Dividend Update

Early September 2016, Metatron Inc. (OTC Pink: MRNJ) filed paperwork with the state of Delaware and federal financial regulators to get a stock dividend approved. Metatron Inc. (OTC Pink: MRNJ) management has recently announced that the paperwork is continuing to be processed by FINRA regulators, and the company is expected to see its dividend record date on October 1, 2016. The stock dividend will be payable on November 2, 2016. Dates and the amount of dividend are subject to change and are contingent upon FINRA approval.

In other words, if you own shares of Metatron Inc (OTC Pink: MRNJ) through the trading day on October 1st, the shareholder will be entitled to 1 share of series B restricted stock for each 100,000 shares of common stock the shareholder owns, which will be payable on November 2, 2016. The series B restricted stock is not subject to reverse stock splits. Again, dates and the amount of dividend are subject to change and are contingent upon FINRA approval.

MRNJ: Financial and Industry Analysis

Now lets turn our focus to Metatron Inc. (OTC Pink: MRNJ)’s financial and industry analysis. Metatron Inc. (OTC Pink: MRNJ) has a market cap of $136,329, as of September 2016. Furthermore, the multi-sector company has a share structure consisting of 1.99 billion shares authorized, 1.36 billion shares outstanding, and a float consisting of 823.3 million shares, as of June 2016. During the second quarter 2016, Metatron Inc. (OTC Pink: MRNJ) reported total revenue of $16,376, cash holdings of $6,229, total assets of $1.24 million, and total liabilities of $270,391. Furthermore, management is forecasting full year 2016 revenues to come in at $300,000.



Being that Metatron Inc. (OTC Pink: MRNJ) is a multi-sector business, there are no exact competitors. However, there are various companies that focus on mobile app development, web development, cannaboid (CBDs) products, and streaming video service. These companies may provide a look into where Metatron Inc. (OTC Pink: MRNJ)’s value could be in the coming years, as management looks to get business activities ramping up again. Five companies worth a look with regards to Metatron Inc. (OTC Pink: MRNJ) include:

AppSwarm, Inc. (OTC Pink: SWRM) is primarily engaged in mobile app development. The company also acquires mobile apps for further development. As of September 2016, AppSwarm, Inc. (OTC Pink: SWRM) has a market cap value of over $12.43 million. Furthermore, the app company lists share structure of 810 million authorized shares and 113.01 million shares outstanding, as of June 2016. During the second quarter 2016, AppSwarm, Inc. (OTC Pink: SWRM) reported no revenue and a net loss of $10,000.

Snap Interactive, Inc. (OTCQB: STVI) is engaged in the development, maintenance, and operation of social dating mobile applications. The company’s dating apps are fully integrated across Android app store, Apple Inc. (NASDAQ: AAPL) app store, Facebook Inc. (NASDAQ: FB), and Web formats. As of September 2016, Snap Interactive, Inc. (OTCQB: STVI) holds a market cap value of $5.95 million. Furthermore, the dating app company has a share structure consisting of 100 million authorized shares, 39.7 million shares outstanding, and a float consisting of 17.5 million shares, as of March 2016. During the second quarter of 2016, Snap Interactive, Inc. (OTCQB: STVI) reported total revenue of over $2.61 million, and a net loss of $841,000.



Medical Marijuana, Inc. (OTC Pink: MJNA) was the first medical marijuana company to be listed on a public stock exchange and specializes in cannaboid (CBDs) and industrial hemp. The company is engaged in the production, extraction, consulting, packaging, processing, and marketing of medical marijuana products and compounds. As of September 2016, Medical Marijuana, Inc. (OTC Pink: MJNA) has a market cap value of nearly $123.35 million. Furthermore, the marijuana company has a share structure consisting of 5 billion authorized shares, 2.87 billion shares outstanding, and a float consisting of 411.05 million shares, as of March 2016. During the second quarter of 2016, Medical Marijuana, Inc. (OTC Pink: MJNA) reported total revenue of $1.73 million, and a net loss of over $4 million.

Web.com Group, Inc. (NASDAQ: WEB) provides a wide range of web services and software to help small businesses and individuals “establish, maintain, promote, and optimize their online presence.” This includes services ranging from simple domain registration and web hosting to web design, e-commerce tools, and subscription solutions. As of September 2016, Web.com Group, Inc. (NASDAQ: WEB) listed a market cap value of $838.9 million, 46.81 million shares outstanding, and a float consisting of 37.33 million shares. During the second quarter of 2016, Web.com Group, Inc. (NASDAQ: WEB) reported total revenue of $187.82 million and a net loss of $1.61 million.

Netflix, Inc. (NASDAQ: NFLX) operates as a streaming video service that provides original TV shows and movies, network TV shows, mainstream movies, and more. Once started as a DVDs-by-mail service, Netflix. Inc. (NASDAQ: NFLX) has since expanded into a subscription streaming video service and has become a pioneer in the emerging industry of streaming video. As previously mentioned, Metatron Inc (OTC Pink: MRNJ) is planning to roll out its own Netflix, Inc. (NASDAQ: NFLX)-style video streaming service, called Appflix. As of September 2016, Netflix, Inc. (NASDAQ: NFLX) had a market cap value of $42.04 billion, 428.73 million shares outstanding, and a float consisting of 421.5 million shares. During the second quarter 2016, Netflix, Inc. (NASDAQ: NFLX) reported total revenue of $2.11 billion and net income of $40.76 million.

Overall, Metatron Inc. (OTC Pink: MRNJ) may have fallen on hard times over the past couple of years, but the company is finally prime for a big comeback. The company continues to be vastly discounted by the market, as seen with market cap value of $136,329 versus total assets of $1.24 million (as of June 2016). Metatron Inc. (OTC Pink: MRNJ) is forecasting 2016 revenues to come in around $300,000, and an even stronger performance in 2017. The multi-sector business is kicking back into full gear. A major focus right now is the full revamp and update of the company’s entire mobile app library from paid apps to free apps, with in-app purchases. Furthermore, Metatron Inc. (OTC Pink: MRNJ)’s CBD drinks are ready for distribution and Appflix, the video streaming service, is currently in development. Myshownetwork.com continues to be a niche business for Metatron Inc. (OTC Pink: MRNJ), as the company has successfully created subscription-based websites for well-known YouTube personalities, self-help authors and more. Overall, Metatron Inc. (OTC Pink: MRNJ) is considered undervalued compared to the company’s assets and revenue outlook. With the revenue engine once again revving back into gear, Metatron Inc. (OTC Pink: MRNJ) is slated for a strong finish to 2016 and beyond.

Disclosure:

All information contained herein as well as on the EmergingGrowth.com website is obtained from sources believed to be reliable but not guaranteed to be accurate or all-inclusive. All material is for informational purposes only, is only the opinion of EmergingGrowth.com and should not be construed as an offer or solicitation to buy or sell securities. The information may include certain forward-looking statements, which may be affected by unforeseen circumstances and / or certain risks. This report is not without bias. EmergingGrowth.com has motivation by means of either self-marketing or EmergingGrowth.com has been compensated by or for a company or companies discussed in this article. Full details about which can be found in our full disclosure, which can be found here, http://www.emerginggrowth.com/disclosure-6765/. Please consult an investment professional before investing in anything viewed within. When EmergingGrowth.com is long shares it will sell those shares. In addition, please make sure you read and understand the Terms of Use, Privacy Policy and the Disclosure posted on the EmergingGrowth.com website.

Metatron Inc (MRNJ) Stock Research Links

MRNJ Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Aurora Innovation Faces Legal Heat Amid Delays

Updated Category News Views 219

Production Snags at Aurora Innovation Ah, investing – not for the faint-hearted. One day you're riding high, the next you're scraping by, and Aurora Innovation's (NASDAQ:AUR) investors just hit a rough patch. The autonomous trucking darling announced unexpected delays in its delivery schedule, sending shockwaves through its stock price and shaking investor confidence....

Continue Reading
Johnson & Johnson Unveils Promising PsA Treatment Data

Updated Category News Views 235

A Game-Changer in Psoriatic Arthritis Treatment? Johnson & Johnson just tossed a headline-grabbing bone into the world of psoriatic arthritis with their new ICOTYDE results. For anyone tangled in the chronic web of psoriatic arthritis, hearing about a potential new treatment like ICOTYDE comes with cautious hope. Between stiff joints and rashy skin, sufferers are often...

Continue Reading
2027 Toy of the Year Finalists Energize Play Market

Updated Category News Views 272

A Kaleidoscope of Innovation in Toys There's a familiar buzz in the air, folks. The 2027 Toy of the Year Awards finalists have been unveiled, and they're bringing a fresh wave of creativity to children's playrooms. These aren't just toys; they're miniature innovators ready to light up the market this holiday season. The reveal happened at the Chicago Toy & Game Fair and...

Continue Reading
7th World Media Summit Spotlights Media's Future in Beijing

Updated Category News Views 235

The Changing Landscape of Global Media An event of this magnitude doesn't just pop up every day like a stock ticker on Wall Street. This year's 7th World Media Summit in Beijing is where nearly 500 bigwigs from all corners of the media landscape are converging. It's not about trading stocks or hitting quarterly numbers—it's about shaping how stories get told in an era...

Continue Reading
J&J's New Study: Sjögren’s Solution Insight Sparks Debate

Updated Category News Views 183

Patient-Centric Take on Sjögren's Disease Johnson & Johnson has dropped fresh Phase 2 results on nipocalimab, reminding everyone they're at the helm of reshaping treatments for Sjögren's disease (SjD). A condition leaving about four million folks craving better days, in multiple ways, shines a light on what's gripping patients the hardest. It's hard not to sit up and...

Continue Reading
Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 347

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading
JOYEE N01 Kicks Off Global Launch with African Orders

Updated Category News Views 319

A New Chapter for JOYEE N01 There's a moment in every company's life when it either steps boldly into the future or stumbles back into obscurity. For FAW Bestune, October 28, 2026, was one of those defining moments. On this day, they launched global mass production of the JOYEE N01 in Yancheng, China. And boy, did they pull out all the stops—you don't see this kind of...

Continue Reading
Off-Broadway Play 'DUST' Raises Autism Support Funds

Updated Category News Views 365

Here's the scoop: an Off-Broadway production just did something many big hitters can't pull off. 'DUST,' a show crafted like a love letter to the American West, managed to rustle up $30,000 for young adults grappled with autism. Partnering with no less than Yale's Cultural Autism Studies and the Ed Asner Family Center, this effort hit the mark in more ways than one. An...

Continue Reading
Paris Baguette Pioneers Drive-Thru in Oklahoma

Updated Category News Views 468

Tapping The Unseen Potential In Bakery Cafes Every so often a business move comes along that makes you sit up and say, "Why the hell haven't they done this before?" Paris Baguette has finally cracked that code, rolling out its first-ever drive-thru in Moore, Oklahoma. Now, imagine yourself zipping through for a croissant without leaving the comfort of your car seat. Makes...

Continue Reading
Invasive Procedures Don't Extend Life in Stable Heart Disease

Updated Category News Views 314

Challenging Longstanding Beliefs Today’s news from the heart research front might set a few cardiology heads spinning. We’ve got big-time findings out of the ISCHEMIA-EXTEND study, throwing more weight on the evidence pile that early invasive heart procedures for patients with stable coronary artery disease don’t actually extend your life. Managing care with a blend...

Continue Reading

Top 5 Most Recently Viewed Articles

Affordable Technology Solutions with Human-I-T's Initiative

Updated Category News Views 184

Human-I-T Launches 'Get It Done' Initiative to Bridge Digital Divide Human-I-T has unveiled its new 'Get It Done' Initiative aimed at making essential technology accessible to everyone without straining their finances. This program focuses on providing quality refurbished laptops at an affordable price, ensuring that individuals and families can benefit from reliable...

Continue Reading
Jasper Street Launches Activism Defense Practice with New Partners

Updated Category News Views 125

Jasper Street Partners Strengthens Activism Defense Practice Jasper Street Partners is gearing up to enhance its defense against activist investors by bringing on board two experienced bankers. Their main objective is clear: to assist clients in identifying weaknesses, navigating proxy contests, and managing the pressures that come with public activism. Introducing New...

Continue Reading
Royalty Pharma's $300 Million Partnership with Zenas BioPharma

Updated Category News Views 139

Funding Agreement for Obexelimab Development Royalty Pharma plc and Zenas BioPharma, Inc. have joined forces in a groundbreaking funding agreement that could inject up to $300 million into the development of obexelimab, a promising treatment for autoimmune diseases, specifically IgG4-Related Disease (IgG4-RD). This alliance highlights Royalty Pharma’s commitment to...

Continue Reading
KBR, Inc. Shares Drop Significantly Following Contract News

Updated Category News Views 242

Significant Decline in KBR, Inc. Shares KBR, Inc. (NYSE: KBR) recently faced a substantial decline in its stock value. This shift came after the announcement regarding the termination of a key contract, leaving many investors anxious about the company's future prospects. The market reacted sharply, indicating the level of uncertainty surrounding KBR's operations and...

Continue Reading
Dr. Mike Varshavski to Address Medical Misinformation Soon

Updated Category News Views 407

Dr. Mike Varshavski to Discuss Medical Misinformation The National Press Club is set to host a compelling event featuring Dr. Mikhail "Dr. Mike" Varshavski, a well-known physician and a social media phenomenon. This exciting Headliners event will take place soon, and attendees can expect an engaging dialogue focused on vital issues surrounding medical misinformation and...

Continue Reading